Featured Posts
Blog
Fauci’s lasting legacy will be the damage he did to science and government
Anthony Fauci isn’t faring well in the court of public opinion. His recently divulged “diary” and subsequent July 29 appearance before the Senate Homeland…
News Release
FDA commissioner resignation opens opportunity for refocus on science over politics
After a somewhat tumultuous tenure, FDA commissioner Marty Makary is stepping down. While Dr. Makary made his mission to accelerate drug approval and bring…
Blog
Don’t hinder biosimilar development
In its most recent legislative session, the Florida legislature considered precluding pharmacy benefit managers (PBMs) from holding an investment interest in biosimilar manufacturing.
Search Posts
National Review
The Supreme Court’s Vaccine Decisions Are a Blow to the Administrative State
The Supreme Court issued a split decision on two of the Biden administration’s Covid-19 vaccination mandates. In the first, a 6–3 majority stayed the Occupational…
New York Post
The Science Shows Eric Adams is Right in Fight to Keep NYC Schools Open
As new cases of the Omicron variant surge, thousands of schools have delayed a return to in-person learning. Cities including Atlanta, Milwaukee, Cleveland and…
City Journal
Omicron’s Silver Lining
New Covid-19 infections are reaching record levels in the U.S. and Europe. The surge is due both to the…
New York Post
New York’s Racial ‘Risk Factor’ for COVID Treatment is Illegal and Immoral
New York City’s and state’s departments of health have reached a divisive and destructive low. In new guidelines rationing scarce, lifesaving oral antiviral medications and…
National Review
Confronting Omicron: One Step Forward, One Step Static
President Joe Biden’s recent address on the Omicron variant was full of holiday miracles. After nearly a year in office, Biden finally conceded…
The Wall Street Journal
Drug Prices Haven’t Been Going Up
Build Back Better may be dead, but its proposed drug price controls will likely reappear: negotiating prices for high-cost drugs in Medicare and price…